DOCSLIB.ORG

Prediction of Alzheimer's Disease Using Multi-Variants from A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prediction of Alzheimer's Disease Using Multi-Variants from A doi:10.1093/brain/awaa364 BRAIN 2020: Page 1 of 14 | 1 Downloaded from https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awaa364/5981992 by Servicio de Salud Extramadura user on 16 November 2020 Prediction of Alzheimer’s disease using multi-variants from a Chinese genome-wide association study Longfei Jia,1 Fangyu Li,1 Cuibai Wei,1 Min Zhu,1 Qiumin Qu,2 Wei Qin,1 Yi Tang,1 Luxi Shen,1 Yanjiang Wang,3 Lu Shen,4 Honglei Li,5 Dantao Peng,6 Lan Tan,7 Benyan Luo,8 Qihao Guo,9 Muni Tang,10 Yifeng Du,11 Jiewen Zhang,12 Junjian Zhang,13 Jihui Lyu,14 Ying Li,1 Aihong Zhou,1 Fen Wang,1 Changbiao Chu,1 Haiqing Song,1 Liyong Wu,1 Xiumei Zuo,1 Yue Han,1 Junhua Liang,1 Qi Wang,1 Hongmei Jin,1 Wei Wang,1 Yang Lu¨,15 Fang Li,16 Yuying Zhou,17 Wei Zhang,18,19 Zhengluan Liao,20 Qiongqiong Qiu,1 Yan Li,1 Chaojun Kong,1 Yan Li,1 Haishan Jiao,1 Jie Lu21,22 and Jianping Jia1,23,24,25 Previous genome-wide association studies have identified dozens of susceptibility loci for sporadic Alzheimer’s disease, but few of these loci have been validated in longitudinal cohorts. Establishing predictive models of Alzheimer’s disease based on these novel variants is clinically important for verifying whether they have pathological functions and provide a useful tool for screening of dis- ease risk. In the current study, we performed a two-stage genome-wide association study of 3913 patients with Alzheimer’s disease –19 and 7593 controls and identified four novel variants (rs3777215, rs6859823, rs234434, and rs2255835; Pcombined = 3.07 Â 10 , 2.49 Â 10–23, 1.35 Â 10–67, and 4.81 Â 10–9, respectively) as well as nine variants in the apolipoprotein E region with genome- wide significance (P 5 5.0 Â 10–8). Literature mining suggested that these novel single nucleotide polymorphisms are related to amyloid precursor protein transport and metabolism, antioxidation, and neurogenesis. Based on their possible roles in the develop- ment of Alzheimer’s disease, we used different combinations of these variants and the apolipoprotein E status and successively built 11 predictive models. The predictive models include relatively few single nucleotide polymorphisms useful for clinical practice, in which the maximum number was 13 and the minimum was only four. These predictive models were all significant and their peak of area under the curve reached 0.73 both in the first and second stages. Finally, these models were validated using a separate lon- gitudinal cohort of 5474 individuals. The results showed that individuals carrying risk variants included in the models had a shorter latency and higher incidence of Alzheimer’s disease, suggesting that our models can predict Alzheimer’s disease onset in a population with genetic susceptibility. The effectiveness of the models for predicting Alzheimer’s disease onset confirmed the contri- butions of these identified variants to disease pathogenesis. In conclusion, this is the first study to validate genome-wide association study-based predictive models for evaluating the risk of Alzheimer’s disease onset in a large Chinese population. The clinical appli- cation of these models will be beneficial for individuals harbouring these risk variants, and particularly for young individuals seek- ing genetic consultation. 1 Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China 2 Department of Neurology, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi, China 3 Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China 4 Department of Neurology, Xiangya Hospital, Central South University, Changsha, China 5 Laboratory of Medical Neurobiology of Zhejiang Province, Zhejiang University School of Medicine, Zhejiang, China 6 Department of Neurology, China-Japan Friendship Hospital, Beijing, China Received February 14, 2020. Revised July 30, 2020. Accepted August 14, 2020. VC The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] 2 | BRAIN 2020: Page 2 of 14 L. Jia et al. 7 Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Shandong, China 8 Department of Neurology, The First Affiliated Hospital, Zhejiang University, Zhejiang, China 9 Department of Gerontology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, China 10 Department of Geriatrics, Guangzhou Huiai Hospital, Affiliated Hospital of Guangzhou Medical College, Guangzhou, China Downloaded from https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awaa364/5981992 by Servicio de Salud Extramadura user on 16 November 2020 11 Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Shandong, China 12 Department of Neurology, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Henan, China 13 Department of Neurology, Zhongnan Hospital, Wuhan University, Hubei, China 14 Center for Cognitive Disorders, Beijing Geriatric Hospital, Beijing, China 15 Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China 16 Department of Geriatric, Fuxing Hospital, Capital Medical University, Beijing, China 17 Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China 18 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China 19 Center for Cognitive Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China 20 Department of Psychiatry, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China 21 Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China 22 Department of Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China 23 Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China 24 Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China 25 Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China Correspondence to: Jianping Jia, MD, PhD Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Changchun Street 45, Xicheng District, Beijing, China, 100053 E-mail: [email protected] Correspondence may also be addressed to: Jie Lu, MD, PhD Department of Radiology, Department of Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Xicheng District, Beijing, China, 100053 E-mail: [email protected] Keywords: Alzheimer’s disease; genome-wide association study; Chinese; predictive model; longitudinal cohort Abbreviations: AUC = area under the curve; eQTL = expression quantitative trait loci; GWAS = genome-wide association study; SNP = single nucleotide polymorphism been identified in the Chinese population (Wang et al., Introduction 2016). A recent whole genome sequencing study in a Alzheimer’s disease is the most common type of dementia Chinese population identified variants in GCH1 and and is genetically complex with an estimated heritability of KCNJ15, in addition to the well-known apolipoprotein E 60–80% (Gatz et al.,1997). Previous genome-wide associ- (APOE) locus; however, the sample size of this study was ation studies (GWASs) of Alzheimer’s disease in Caucasian, relatively small (Zhou et al.,2018). African-American, and Asian populations have identified Recently, genetic predictive models have been established genetic risk variants in ABCA7, BIN1, CASS4, CD2AP, for predicting the onset of Alzheimer’s disease using a poly- CD33, CDK5RAP2, CELF1, CLU, COBL, CR1, genic risk score approach, which was used to reveal polygen- ECHDC3, EPHA1, EXOC3L2, FERMT2, HLA-DRB5, etic contributions to Alzheimer’s disease risk of common HLA-DRB1, HS3ST1, INPP5D, KANSL1, MEF2C, MS4A, single nucleotide polymorphisms (SNPs) that show a disease NME8, PICALM, PM20D1, PTK2B, SLC10A2, SLC24A4, association but fail to meet the accepted P-value threshold SORL1, TREM2,andZCWPW1 (Harold et al.,2009; for genome-wide significance (Escott-Price et al.,2015, Lambert et al., 2009, 2013a; Seshadri et al.,2010; 2017a, b, 2019; Chouraki et al.,2016; Stocker et al.,2018; Hollingworth et al.,2011; Naj et al.,2011; Guerreiro et al., Leonenko et al.,2019). These studies showed variable 2013; Miyashita et al.,2013; Reitz et al.,2013; Desikan results. Specifically, Escott-Price et al. reported that the area et al.,2015; Jun et al.,2016; Lacour et al.,2017; Miron under the curve (AUC) of their predictive models, which et al.,2018; Sanchez-Mut et al.,2018; Kunkle et al.,2019). included APOE, 480 000 SNPs, age, and sex as predictors, These variants affect several Alzheimer’s disease-related was 0.78, whereas in their other study, the AUC of their processes, such as lipid metabolism, inflammation, innate models including 420 000 SNPs and APOE as predictors immunity, production and clearance of amyloid-b,and increased to 0.84 as the included individuals
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Systems Genetics of Sensation Seeking. Price E
    The Jackson Laboratory The Mouseion at the JAXlibrary Faculty Research 2019 Faculty Research 3-2019 Systems genetics of sensation seeking. Price E. Dickson Tyler A Roy Kathryn A. McNaughton Troy Wilcox Padam Kumar See next page for additional authors Follow this and additional works at: https://mouseion.jax.org/stfb2019 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons Authors Price E. Dickson, Tyler A Roy, Kathryn A. McNaughton, Troy Wilcox, Padam Kumar, and Elissa J Chesler Received: 20 May 2018 Revised: 9 September 2018 Accepted: 11 September 2018 DOI: 10.1111/gbb.12519 ORIGINAL ARTICLE Systems genetics of sensation seeking Price E. Dickson | Tyler A. Roy | Kathryn A. McNaughton | Troy D. Wilcox | Padam Kumar | Elissa J. Chesler Center for Systems Neurogenetics of Addiction, The Jackson Laboratory, Bar Sensation seeking is a multifaceted, heritable trait which predicts the development of substance Harbor, Maine use and abuse in humans; similar phenomena have been observed in rodents. Genetic correla- Correspondence tions among sensation seeking and substance use indicate shared biological mechanisms, but Price E. Dickson, The Jackson Laboratory, the genes and networks underlying these relationships remain elusive. Here, we used a systems 600 Main Street, Bar Harbor, ME 04609 Email: [email protected] genetics approach in the BXD recombinant inbred mouse panel to identify shared genetic mech- Elissa J. Chesler, The Jackson Laboratory, anisms underlying substance use and preference for sensory stimuli, an intermediate phenotype 600 Main Street, Bar Harbor, ME 04609 of sensation seeking. Using the operant sensation seeking (OSS) paradigm, we quantified prefer- Email: [email protected] ence for sensory stimuli in 120 male and 127 female mice from 62 BXD strains and the Funding information C57BL/6J and DBA/2J founder strains.
    [Show full text]
  • A Bootstrap-Based Regression Method for Comprehensive Discovery of Differential Gene Expressions: an Application to the Osteoporosis Study
    A bootstrap-based regression method for comprehensive discovery of differential gene expressions: an application to the osteoporosis study Yan Lu1,2, Yao-Zhong Liu3, Peng–Yuan Liu2, Volodymyr Dvornyk4, and Hong–Wen Deng1,3 1. College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, P. R. China 2. Department of Physiology and the Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA 3. Department of Biostatistics and Bioinformatics & Center for Bioinformatics and Genomics, Tulane University School of Public Health, New Orleans, LA 70112, USA 4. School of Biological Sciences, University of Hong Kong, Pokfulam Rd., Pokfulam, Hong Kong, P.R. China Running title: Bootstrap-based regression method for microarray analysis Key words: microarray, bootstrap, regression, osteoporosis Corresponding author: Hong–Wen Deng, Ph. D. Department of Biostatistics and Bioinformatics & Center for Bioinformatics and Genomics, Tulane University School of Public Health, 1440 Canal Street, Suite 2001, New Orleans, LA 70112 Tel: 504-988-1310 Email: [email protected] 1 Abstract A common purpose of microarray experiments is to study the variation in gene expression across the categories of an experimental factor such as tissue types and drug treatments. However, it is not uncommon that the studied experimental factor is a quantitative variable rather than categorical variable. Loss of information would occur by comparing gene-expression levels between groups that are factitiously defined according to the quantitative threshold values of an experimental factor. Additionally, lack of control for some sensitive clinical factors may bring serious false positive or negative findings. In the present study, we described a bootstrap-based regression method for analyzing gene expression data from the non-categorical microarray experiments.
    [Show full text]
  • Atypical Rho Gtpases of the Rhobtb Subfamily: Roles in Vesicle Trafficking and Tumorigenesis
    cells Review Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis Wei Ji 1 and Francisco Rivero 2,* 1 School of Life Science and Technology, Changchun University of Science and Technology, Changchun 130022, China; [email protected] 2 Centre for Cardiovascular and Metabolic Research, Hull York Medical School, University of Hull, Cottingham Road, Hull, East Riding of Yorkshire HU6 7RX, UK * Correspondence: [email protected]; Tel.: +44-1482-466-433 Academic Editor: Bor Luen Tang Received: 17 May 2016; Accepted: 8 June 2016; Published: 14 June 2016 Abstract: RhoBTB proteins constitute a subfamily of atypical Rho GTPases represented in mammals by RhoBTB1, RhoBTB2, and RhoBTB3. Their characteristic feature is a carboxyl terminal extension that harbors two BTB domains capable of assembling cullin 3-dependent ubiquitin ligase complexes. The expression of all three RHOBTB genes has been found reduced or abolished in a variety of tumors. They are considered tumor suppressor genes and recent studies have strengthened their implication in tumorigenesis through regulation of the cell cycle and apoptosis. RhoBTB3 is also involved in retrograde transport from endosomes to the Golgi apparatus. One aspect that makes RhoBTB proteins atypical among the Rho GTPases is their proposed mechanism of activation. No specific guanine nucleotide exchange factors or GTPase activating proteins are known. Instead, RhoBTB might be activated through interaction with other proteins that relieve their auto-inhibited conformation and inactivated through auto-ubiquitination and destruction in the proteasome. In this review we discuss our current knowledge on the molecular mechanisms of action of RhoBTB proteins and the implications for tumorigenesis and other pathologic conditions.
    [Show full text]
  • Rho Gtpases of the Rhobtb Subfamily and Tumorigenesis1
    Acta Pharmacol Sin 2008 Mar; 29 (3): 285–295 Invited review Rho GTPases of the RhoBTB subfamily and tumorigenesis1 Jessica BERTHOLD2, Kristína SCHENKOVÁ2, Francisco RIVERO2,3,4 2Centers for Biochemistry and Molecular Medicine, University of Cologne, Cologne, Germany; 3The Hull York Medical School, University of Hull, Hull HU6 7RX, UK Key words Abstract Rho guanosine triphosphatase; RhoBTB; RhoBTB proteins constitute a subfamily of atypical members within the Rho fa- DBC2; cullin; neoplasm mily of small guanosine triphosphatases (GTPases). Their most salient feature 1This work was supported by grants from the is their domain architecture: a GTPase domain (in most cases, non-functional) Center for Molecular Medicine Cologne, the is followed by a proline-rich region, a tandem of 2 broad-complex, tramtrack, Deutsche Forschungsgemeinschaft, and the bric à brac (BTB) domains, and a conserved C-terminal region. In humans, Köln Fortune Program of the Medical Faculty, University of Cologne. the RhoBTB subfamily consists of 3 isoforms: RhoBTB1, RhoBTB2, and RhoBTB3. Orthologs are present in several other eukaryotes, such as Drosophi- 4 Correspondence to Dr Francisco RIVERO. la and Dictyostelium, but have been lost in plants and fungi. Interest in RhoBTB Phn 49-221-478-6987. Fax 49-221-478-6979. arose when RHOBTB2 was identified as the gene homozygously deleted in E-mail [email protected] breast cancer samples and was proposed as a candidate tumor suppressor gene, a property that has been extended to RHOBTB1. The functions of RhoBTB pro- Received 2007-11-17 Accepted 2007-12-16 teins have not been defined yet, but may be related to the roles of BTB domains in the recruitment of cullin3, a component of a family of ubiquitin ligases.
    [Show full text]
  • Combinatorial Strategies Using CRISPR/Cas9 for Gene Mutagenesis in Adult Mice
    Combinatorial strategies using CRISPR/Cas9 for gene mutagenesis in adult mice Avery C. Hunker A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2019 Reading Committee: Larry S. Zweifel, Chair Sheri J. Mizumori G. Stanley McKnight Program Authorized to Offer Degree: Pharmacology 2 © Copyright 2019 Avery C. Hunker 3 University of Washington ABSTRACT Combinatorial strategies using CRISPR/Cas9 for gene mutagenesis in adult mice Avery C. Hunker Chair of the Supervisory Committee: Larry Zweifel Department of Pharmacology A major challenge to understanding how genes modulate complex behaviors is the inability to restrict genetic manipulations to defined cell populations or circuits. To circumvent this, we created a simple strategy for limiting gene knockout to specific cell populations using a viral-mediated, conditional CRISPR/SaCas9 system in combination with intersectional genetic strategies. A small single guide RNA (sgRNA) directs Staphylococcus aureus CRISPR-associated protein (SaCas9) to unique sites on DNA in a Cre-dependent manner resulting in double strand breaks and gene mutagenesis in vivo. To validate this technique we targeted nine different genes of diverse function in distinct cell types in mice and performed an array of analyses to confirm gene mutagenesis and subsequent protein loss, including IHC, cell-type specific DNA sequencing, electrophysiology, Western blots, and behavior. We show that these vectors are as efficient as conventional conditional gene knockout and provide a viable alternative to complex genetic crosses. This strategy provides additional benefits of 4 targeting gene mutagenesis to cell types previously difficult to isolate, and the ability to target genes in specific neural projections for gene inactivation.
    [Show full text]
  • Supplementary Data
    Supplemental figures Supplemental figure 1: Tumor sample selection. A total of 98 thymic tumor specimens were stored in Memorial Sloan-Kettering Cancer Center tumor banks during the study period. 64 cases corresponded to previously untreated tumors, which were resected upfront after diagnosis. Adjuvant treatment was delivered in 7 patients (radiotherapy in 4 cases, cyclophosphamide- doxorubicin-vincristine (CAV) chemotherapy in 3 cases). 34 tumors were resected after induction treatment, consisting of chemotherapy in 16 patients (cyclophosphamide-doxorubicin- cisplatin (CAP) in 11 cases, cisplatin-etoposide (PE) in 3 cases, cisplatin-etoposide-ifosfamide (VIP) in 1 case, and cisplatin-docetaxel in 1 case), in radiotherapy (45 Gy) in 1 patient, and in sequential chemoradiation (CAP followed by a 45 Gy-radiotherapy) in 1 patient. Among these 34 patients, 6 received adjuvant radiotherapy. 1 Supplemental Figure 2: Amino acid alignments of KIT H697 in the human protein and related orthologs, using (A) the Homologene database (exons 14 and 15), and (B) the UCSC Genome Browser database (exon 14). Residue H697 is highlighted with red boxes. Both alignments indicate that residue H697 is highly conserved. 2 Supplemental Figure 3: Direct comparison of the genomic profiles of thymic squamous cell carcinomas (n=7) and lung primary squamous cell carcinomas (n=6). (A) Unsupervised clustering analysis. Gains are indicated in red, and losses in green, by genomic position along the 22 chromosomes. (B) Genomic profiles and recurrent copy number alterations in thymic carcinomas and lung squamous cell carcinomas. Gains are indicated in red, and losses in blue. 3 Supplemental Methods Mutational profiling The exonic regions of interest (NCBI Human Genome Build 36.1) were broken into amplicons of 500 bp or less, and specific primers were designed using Primer 3 (on the World Wide Web for general users and for biologist programmers (see Supplemental Table 2) [1].
    [Show full text]
  • Anti-Proliferative Effect of Estrogen in Breast Cancer Cells That Re-Express Erα Is Mediated by Aberrant Regulation of Cell
    535 Anti-proliferative effect of estrogen in breast cancer cells that re-express ER is mediated by aberrant regulation of cell cycle genes J G Moggs, T C Murphy, F L Lim, D J Moore, R Stuckey, K Antrobus, I Kimber and G Orphanides Syngenta CTL, Alderley Park, Cheshire SK10 4TJ, UK (Requests for offprints should be addressed to J G Moggs; Email: [email protected]) Abstract Estrogen receptor (ER)-negative breast carcinomas do not respond to hormone therapy, making their effective treatment very difficult. The re-expression of ER in ER-negative MDA-MB-231 breast cancer cells has been used as a model system, in which hormone-dependent responses can be restored. Paradoxically, in contrast to the mitogenic activity of 17-estradiol (E2) in ER-positive breast cancer cells, E2 suppresses proliferation in ER-negative breast cancer cells in which ER has been re-expressed. We have used global gene expression profiling to investigate the mechanism by which E2 suppresses proliferation in MDA-MB-231 cells that express ER through adenoviral infection. We show that a number of genes known to promote cell proliferation and survival are repressed by E2 in these cells. These include genes encoding the anti-apoptosis factor SURVIVIN, positive cell cycle regulators (CDC2, CYCLIN B1, CYCLIN B2, CYCLIN G1, CHK1, BUB3, STK6, SKB1, CSE1 L) and chromosome replication proteins (MCM2, MCM3, FEN1, RRM2, TOP2A, RFC1). In parallel, E2-induced the expression of the negative cell cycle regulators KIP2 and QUIESCIN Q6, and the tumour-suppressor genes E-CADHERIN and NBL1. Strikingly, the expression of several of these genes is regulated in the opposite direction by E2 compared with their regulation in ER-positive MCF-7 cells.
    [Show full text]
  • Visual Gene Network Analysis of Aging-Specific Gene Co-Expression
    4open 2018, 1,4 © B.P. Parida et al., Published by EDP Sciences 2018 https://doi.org/10.1051/fopen/2018004 Available online at: www.4open-sciences.org RESEARCH ARTICLE Visual gene network analysis of aging-specific gene co-expression in human indicates overlaps with immuno-pathological regulations Bibhu Prasad Parida1,*, Biswapriya Biswavas Misra2, Amarendra Narayan Misra3,4 1 Post-Graduate Department of Biosciences and Biotechnology, School of Biotechnology, Fakir Mohan University, Balasore 756020, Odisha, India 2 Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem 27157, NC, USA 3 Central University of Jharkhand, Brambe, Ratu-Lohardaga Road, Ranchi 835205, Jharkhand, India 4 Khallikote University, Berhampur 760001, Odisha, India Received 19 September 2017, Accepted 4 July 2018 Abstract- - Introduction: Aging is a complex biological process that brings about a gradual decline of physiological and metabolic machineries as a result of maturity. Also, aging is irreversible and leads ultimately to death in biological organisms. Methods: We intend to characterize aging at the gene expression level using publicly available human gene expression arrays obtained from gene expression omnibus (GEO) and ArrayExpress. Candidate genes were identified by rigorous screening using filtered data sets, i.e., GSE11882, GSE47881, and GSE32719. Using Aroma and Limma packages, we selected the top 200 genes showing up and down regulation (p < 0.05 and fold change >2.5) out of which 185 were chosen for further comparative analysis. Results: This investigation enabled identification of candidate genes involved in aging that are associated with several signaling cascades demonstrating strong correlation with ATP binding and protease functions.
    [Show full text]
  • Prenylcysteine Oxidase 1, a Pro-Oxidant Enzyme of Low Density Lipoproteins
    [Frontiers In Bioscience, Landmark, 23, 1020-1037, January 1, 2018] Prenylcysteine oxidase 1, a pro-oxidant enzyme of low density lipoproteins Luis V. Herrera-Marcos,1,2 Jose M. Lou-Bonafonte,2,3,4 Maria V. Martinez-Gracia,4 Carmen Arnal,2,4,5 Maria A. Navarro,1,2,4 Jesus Osada1,2,4 1Departamento de Bioquimica y Biologia Molecular y Celular, Facultad de Veterinaria, Instituto de Investigacion Sanitaria de Aragon-Universidad de Zaragoza, Zaragoza, E-50013, Spain, 2Instituto Agroalimentario de Aragon, CITA-Universidad de Zaragoza, Spain, 3Departamento de Farmacologia y Fisiologia, Facultad de Ciencias de la Salud y del Deporte, Instituto de Investigacion Sanitaria de Aragon-Universidad de Zaragoza, Huesca, E-22002, Spain, 4CIBER de Fisiopatologia de la Obesidad y Nutricion, Instituto de Salud Carlos III, Madrid, E-28029, Spain, 5Departamento de Patologia Animal, Facultad de Veterinaria, Instituto de Investigacion Sanitaria de Aragon-Universidad de Zaragoza, Zaragoza, E-50013, Spain Table OF CONTENTS 1. Abstract 2. Introduction 3. Human PCYOX1 gene 3.1. Gene polymorphisms 3.2. Hepatic PCYOX1 transcripts 3.3. Hepatic PCYOX1 transcriptional regulation 3.4. Hepatic PCYOX1 post-transcriptional regulation 4. PCYOX1 Protein 4.1. Post-translational modifications (PTMs) 4.2. Protein structure and function 4.3. Protein interactions 5. PCYOX1 in physiology and disease 5.1. Lipoproteins 5.2. Pcyox1-deficient mice 5.3. PCYOX1 and the liver 5.4. PCYOX1 gene and cancer 5.5. PCYOX1 and neurodegenerative diseases 5.6. PCYOX1 and obesity 6. Conclusions 7. Acknowledgments 8. References 1. ABSTRACT Elevated levels of low density lipoproteins has yet been associated with any disease.
    [Show full text]
  • (B6;129.Cg-Gt(ROSA)26Sor Tm20(CAG-Ctgf-GFP)Jsd) Were Crossed with Female Foxd1cre/+ Heterozygote Mice 1, and Experimental Mice Were Selected As Foxd1cre/+; Rs26cig/+
    Supplemental Information SI Methods Animal studies Heterozygote mice (B6;129.Cg-Gt(ROSA)26Sor tm20(CAG-Ctgf-GFP)Jsd) were crossed with female Foxd1Cre/+ heterozygote mice 1, and experimental mice were selected as Foxd1Cre/+; Rs26CIG/+. In some studies Coll-GFPTg or TCF/Lef:H2B-GFPTg mice or Foxd1Cre/+; Rs26tdTomatoR/+ mice were used as described 2; 3. Left kidneys were subjected to ureteral obstruction using a posterior surgical approach as described 2. In some experiments recombinant mouse DKK1 (0.5mg/kg) or an equal volume of vehicle was administered by daily IP injection. In the in vivo ASO experiment, either specific Lrp6 (TACCTCAATGCGATTT) or scrambled negative control ASO (AACACGTCTATACGC) (30mg/kg) (Exiqon, LNA gapmers) was administered by IP injection on d-1, d1, d4, and d7. In other experiments anti-CTGF domain-IV antibodies (5mg/kg) or control IgG were administered d-1, d1 and d6. All animal experiments were performed under approved IACUC protocols held at the University of Washington and Biogen. Recombinant protein and antibody generation and characterization Human CTGF domain I (sequence Met1 CPDEPAPRCPAGVSLVLDGCGCCRVCAKQLGELCTERDPCDPHKGLFC), domain I+II (sequence Met1CPDEPAPRCPAGVSLVLDGCGCCRVCAKQLGELCTERDPCDPHKGLFCCIFGGT VYRSGESFQSSCKYQCTCLDGAVGCMPLCSMDVRLPSPDCPFPRRVKLPGKCCEE) were cloned and expressed in 293 cells, and purified by Chelating SFF(Ni) Column, tested for single band by SEC and PAGE, and tested for absence of contamination. Domain-IV (sequence GKKCIRTPKISKPIKFELSGCTSMKTYRAKFCGVCTDGRCCTPHRTTTLPVEFKCPDGE VMKKNMMFIKTCACHYNCPGDNDIFESLYYRKMY) was purchased from Peprotech. Mouse or human DKK1 was generated from the coding sequence with some modifications and a tag. Secreted protein was harvested from 293 cells, and purified by nickel column, and tested for activity in a supertopflash (STF) assay 4. DKK1 showed EC50 of 0.69nM for WNT3a-induced WNT signaling in STF cells.
    [Show full text]
  • Atypical Rho Gtpases of the Rhobtb Subfamily: Roles in Vesicle Trafficking and Tumorigenesis
    Review Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis Wei Ji 1 and Francisco Rivero 2,* 1 School of Life Science and Technology, Changchun University of Science and Technology, Changchun 130022, China; [email protected] 2 Centre for Cardiovascular and Metabolic Research, Hull York Medical School, University of Hull, Cottingham Road, Hull, East Riding of Yorkshire HU6 7RX, UK * Correspondence: [email protected]; Tel.: +44-1482466433 Academic Editor: Bor Luen Tang Received: 17 May 2016; Accepted: 8 June 2016; Published: date Abstract: RhoBTB proteins constitute a subfamily of atypical Rho GTPases represented in mammals by RhoBTB1, RhoBTB2, and RhoBTB3. Their characteristic feature is a carboxyl terminal extension that harbors two BTB domains capable of assembling cullin 3-dependent ubiquitin ligase complexes. The expression of all three RHOBTB genes has been found reduced or abolished in a variety of tumors. They are considered tumor suppressor genes and recent studies have strengthened their implication in tumorigenesis through regulation of the cell cycle and apoptosis. RhoBTB3 is also involved in retrograde transport from endosomes to the Golgi apparatus. One aspect that makes RhoBTB proteins atypical among the Rho GTPases is their proposed mechanism of activation. No specific guanine nucleotide exchange factors or GTPase activating proteins are known. Instead, RhoBTB might be activated through interaction with other proteins that relieve their auto-inhibited conformation and inactivated through auto-ubiquitination and destruction in the proteasome. In this review we discuss our current knowledge on the molecular mechanisms of action of RhoBTB proteins and the implications for tumorigenesis and other pathologic conditions.
    [Show full text]